WEST FRONT STRATEGIES LLC for VIATRIS INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Issues related to the antitrust review of Teva Pharmaceuticals Industries, Ltd. offer to acquire Mylan N.V.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| ASHLEY DAVIS | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Trade (domestic/foreign) TRD
Issues related to the intellectual property provisions in the Trans-Pacific Partnership negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| ASHLEY DAVIS | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| ASHLEY DAVIS | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Copyright/Patent/Trademark CPT
Issues related to patent litigation reform, including H.R. 9, the Innovation Act; S. 632, the STRONG Patents Act; and S. 1137, the PATENT Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| ASHLEY DAVIS | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Health Issues HCR
Issues related to implementation of the Generic Drug User Fee Agreement; Issues related to H.R. 6, 21st Century Cures Initiative and Senate HELP Innovation Initiative; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; FDA proposed rule, Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products; Issues related to generic drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| ASHLEY DAVIS | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Budget/Appropriations BUD
FY 2016 Agriculture/FDA Appropriations, in particular, FDA funding and sequestration of user fees; FY 2016 State/Foreign Operations Appropriations, in particular, PEPFAR funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| ASHLEY DAVIS | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.